NGMDF (NuGen Medical Devices) Stock Based Compensation: $0.00 Mil (TTM As of Mar. 2026)


What is NuGen Medical Devices Stock Based Compensation?

NuGen Medical Devices NGMDF Stock Based Compensation is $0.00 Mil as of Mar. 2026. The stock has 7 warning signs investors should review.

NuGen Medical Devices's Stock Based Compensation for the three months ended in Mar. 2026 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.


NuGen Medical Devices Stock Based Compensation Related Terms


NuGen Medical Devices Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for NuGen Medical Devices's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices Stock Based Compensation Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 1.02 0.32 1.02 0.07 0.00

NuGen Medical Devices Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NuGen Medical Devices Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
NuGen Medical Devices (NGMDF) has a Stock Based Compensation of $0.00 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for NuGen Medical Devices and its competitors.
Is NuGen Medical Devices' Stock Based Compensation too high?
NuGen Medical Devices' current Stock Based Compensation is $0.00 Mil.
How does NuGen Medical Devices' Stock Based Compensation compare to ABT and SYK?
NuGen Medical Devices' Stock Based Compensation of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for NuGen Medical Devices and its competitors. NuGen Medical Devices's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 21.8% below its estimated fair value. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current Stock Based Compensation is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NuGen Medical Devices Business Description

Other Exchanges 79O:GermanyNGMD:Canada
Address 18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.